CN Stock MarketDetailed Quotes

688180 Shanghai Junshi Biosciences Co., Ltd.

Watchlist
  • 30.96
  • -0.08-0.26%
Market Closed Dec 13 15:00 CST
30.52BMarket Cap-16.92P/E (TTM)

Shanghai Junshi Biosciences Co., Ltd. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
-40.64%2.47B
-44.45%2.71B
-9.10%4.56B
-37.19%3.79B
36.03%4.17B
40.62%4.88B
17.75%5.02B
71.98%6.03B
-2.63%3.06B
-18.70%3.47B
Transactional financial assets
--570M
--600M
----
----
----
----
--400M
----
----
----
Notes receivable and accounts receivable
27.63%466.69M
-7.78%449.9M
63.98%492.08M
102.88%483.23M
26.27%365.65M
126.23%487.86M
-14.86%300.08M
-81.69%238.19M
-61.23%289.59M
-51.06%215.65M
-Accounts receivable
27.63%466.69M
-7.78%449.9M
63.98%492.08M
102.88%483.23M
26.27%365.65M
126.23%487.86M
-14.86%300.08M
-81.58%238.19M
-58.45%289.59M
-43.75%215.65M
Other receivables (including interest and dividends)
118.62%201.57M
328.22%201.79M
772.70%230.54M
1,328.69%374.01M
371.18%92.2M
57.86%47.12M
-49.28%26.42M
-6.68%26.18M
-33.71%19.57M
256.64%29.85M
-Other receivable
----
328.22%201.79M
----
1,328.69%374.01M
----
57.86%47.12M
----
-6.68%26.18M
----
256.64%29.85M
Advance payment
-0.51%283.15M
6.93%267.24M
-36.46%230.65M
3.38%238.9M
1.68%284.6M
-24.01%249.92M
-11.71%362.99M
-40.71%231.08M
-40.36%279.88M
-18.84%328.87M
Inventories
-24.13%567.44M
-15.08%554.11M
-7.70%535.55M
-10.18%538.05M
39.21%747.92M
20.98%652.53M
13.95%580.24M
23.61%599.02M
33.84%537.28M
30.27%539.35M
Non-current assets due within one year
1,244.10%4.75M
322.69%9.34M
95.16%7.28M
162.92%8.18M
-85.18%353.16K
12.96%2.21M
60.73%3.73M
103.07%3.11M
2.82%2.38M
-28.49%1.96M
Other current assets
-85.93%17.33M
-73.83%26.79M
35.77%138.42M
59.38%140.51M
80.50%123.2M
95.36%102.38M
-29.16%101.95M
-33.96%88.16M
11.93%68.25M
-10.43%52.4M
Total current assets
-20.71%4.59B
-24.95%4.82B
-8.80%6.19B
-22.80%5.57B
35.69%5.78B
38.46%6.42B
18.50%6.79B
23.47%7.22B
-12.27%4.26B
-17.15%4.64B
Non Current assets
Other equity investment
-34.89%43.57M
-26.99%56.13M
-28.04%84.29M
-38.76%84.18M
-60.64%66.92M
-36.50%76.89M
-42.65%117.13M
-45.79%137.46M
-34.53%170.03M
-45.61%121.09M
Other non-current financial assets
-4.20%825.3M
3.51%799.2M
8.70%830.2M
4.35%806.35M
12.57%861.49M
1.72%772.12M
-2.33%763.76M
-0.10%772.74M
-0.86%765.3M
6.49%759.1M
Fixed assets
----
22.68%2.36B
----
28.36%2.43B
----
5.53%1.93B
----
0.66%1.89B
----
-4.17%1.83B
Constru in process
----
26.28%1.53B
----
26.99%1.33B
----
28.06%1.21B
----
30.14%1.04B
----
81.67%943.33M
Intangible assets
41.70%526.5M
71.28%533.02M
73.29%540.3M
73.04%546.96M
16.63%371.57M
-3.84%311.2M
-3.52%311.8M
19.29%316.09M
94.17%318.6M
94.39%323.64M
Long deferred expense
-51.02%8.02M
-46.48%10.82M
-54.44%9.92M
-45.79%12.6M
-31.09%16.36M
-19.96%20.21M
-18.27%21.78M
-16.37%23.24M
-12.56%23.75M
-6.10%25.25M
Deferred tax assets
-41.72%103.2M
-40.80%102.23M
-55.56%100.55M
-54.74%103.4M
38.75%177.09M
37.19%172.69M
155.52%226.26M
157.96%228.43M
51.29%127.64M
125.30%125.87M
Usufruct assets
-11.50%50.61M
-53.56%30.22M
-40.87%43.36M
-37.32%51.37M
-65.12%57.18M
-63.00%65.06M
-40.78%73.32M
-30.11%81.95M
48.39%163.93M
67.47%175.84M
Other non current assets
39.74%477.3M
32.39%453.9M
-48.04%186.65M
-52.40%167.14M
-2.61%341.56M
-13.79%342.85M
-19.13%359.19M
-32.77%351.17M
-34.71%350.7M
-21.16%397.67M
Total non current assets
8.06%6.27B
15.16%6.17B
9.20%5.83B
8.05%5.77B
9.12%5.8B
2.08%5.36B
2.25%5.34B
2.93%5.34B
12.37%5.32B
18.49%5.25B
Total assets
-6.30%10.86B
-6.71%10.99B
-0.88%12.02B
-9.68%11.34B
20.94%11.59B
19.15%11.78B
10.75%12.13B
13.81%12.56B
-0.11%9.58B
-1.41%9.89B
Liabilities
Current liabilities
Short term loan
86.04%631.66M
93.37%667.17M
249.13%1.23B
28.77%452.44M
-24.26%339.52M
77.28%345.03M
--353.12M
--351.36M
82,652.92%448.24M
824.82%194.63M
Notes payable and accounts payable
-11.15%984.19M
-11.50%1.03B
5.96%1.12B
31.05%1.39B
23.02%1.11B
26.06%1.16B
-35.35%1.06B
-33.29%1.06B
3.60%900.48M
26.25%923.19M
-Notes payable
----
----
--4.67M
--4.67M
----
----
----
----
----
----
-Accounts payable
-11.15%984.19M
-11.50%1.03B
5.52%1.12B
30.61%1.38B
23.02%1.11B
26.06%1.16B
-35.33%1.06B
-33.27%1.06B
3.63%900.48M
26.25%923.19M
Contract liabilities
98.57%162.98M
289.38%154.28M
343.12%146.45M
3,455.43%146.3M
747.88%82.08M
129.24%39.62M
12.08%33.05M
-91.02%4.11M
-87.02%9.68M
-70.76%17.28M
Salaries payable
50.46%232.6M
38.33%191.85M
61.54%258.23M
22.04%234.2M
10.93%154.59M
22.56%138.69M
12.85%159.85M
-10.23%191.9M
11.66%139.36M
-18.93%113.16M
Taxs payable
70.48%35.57M
48.08%36.31M
22.13%29.65M
44.51%50.74M
-15.03%20.87M
19.34%24.52M
-52.37%24.28M
-53.85%35.11M
-26.16%24.56M
-14.36%20.55M
Other payable (including interest and dividends)
-8.83%36.18M
34.75%43.64M
49.98%50.41M
-11.61%37.33M
38.14%39.69M
-24.59%32.39M
-0.00%33.61M
37.55%42.23M
-26.96%28.73M
-14.10%42.95M
-Other payable
----
34.75%43.64M
----
-11.61%37.33M
----
-24.59%32.39M
----
37.55%42.23M
----
-14.10%42.95M
Non current liabilities due within one year
103.24%213.79M
63.01%154.43M
27.36%122.11M
46.20%122.89M
28.46%105.19M
27.15%94.74M
55.87%95.88M
86.50%84.05M
108.16%81.89M
-84.18%74.51M
Other current liabilities
-97.97%617.73
15,811.73%8.56M
12,383.07%8.54M
11,483.62%8.69M
-75.64%30.42K
-89.05%53.82K
-92.13%68.42K
-98.46%74.99K
-98.69%124.86K
-94.93%491.66K
Total current liabilities
24.18%2.3B
24.33%2.29B
68.94%2.97B
38.05%2.44B
13.27%1.85B
32.60%1.84B
-10.05%1.76B
-11.75%1.77B
37.17%1.63B
-7.89%1.39B
Current liabilities
Estimate liabilities
--17.62M
--17.62M
--20.47M
--27.1M
----
----
----
----
----
----
Long term deferred income
2.21%175.54M
4.50%177.2M
19.97%180.92M
50.31%183.46M
40.50%171.74M
38.61%169.58M
26.20%150.8M
-0.33%122.06M
8.49%122.24M
20.33%122.34M
Lease liabilities
-1.72%24.8M
-68.47%9.52M
-60.47%15.32M
-62.54%17.45M
-81.56%25.23M
-78.92%30.2M
-58.72%38.74M
-49.98%46.58M
50.99%136.79M
70.35%143.22M
Other non current liabilities
-1.02%157.02M
743.09%155.6M
2,696.13%161.45M
2,032.92%160.05M
1,770.45%158.64M
115.96%18.46M
-42.63%5.77M
-34.74%7.5M
-35.66%8.48M
-42.94%8.55M
Total non current liabilities
62.94%2.28B
81.65%2.1B
85.29%2.04B
55.93%1.58B
34.12%1.4B
19.10%1.16B
57.44%1.1B
41.65%1.02B
47.46%1.04B
103.09%969.9M
Total liabilities
40.88%4.58B
46.44%4.38B
75.23%5.01B
44.58%4.02B
21.40%3.25B
27.04%2.99B
7.73%2.86B
2.34%2.78B
41.00%2.68B
18.84%2.36B
Shareholders equity
Paid-in capital
0.00%985.69M
0.00%985.69M
0.00%985.69M
0.29%985.69M
8.01%985.69M
8.01%985.69M
8.23%985.69M
7.92%982.87M
0.20%912.6M
0.20%912.6M
Capital reserve funds
-0.01%15.39B
0.04%15.39B
0.10%15.39B
0.32%15.39B
32.19%15.4B
32.43%15.39B
31.34%15.38B
34.34%15.35B
7.57%11.65B
7.43%11.62B
Retained profit
-22.04%-9.99B
-24.84%-9.71B
-27.64%-9.34B
-33.70%-9.06B
-36.77%-8.18B
-46.65%-7.77B
-52.98%-7.32B
-54.42%-6.78B
-47.38%-5.98B
-44.90%-5.3B
Less:Treasury stock
105.54%30.89M
--30.89M
--29.89M
--26.89M
--15.03M
----
----
----
----
----
Other composite income
-59.48%-190.01M
-56.13%-166.41M
-47.32%-141.21M
-107.67%-142.07M
-467.82%-119.14M
-3.72%-106.59M
-90.29%-95.86M
-32,803.91%-68.41M
-246.80%-20.98M
-325.78%-102.76M
Shareholders equity without minority interests
-23.46%6.17B
-23.73%6.48B
-23.28%6.87B
-24.59%7.15B
23.02%8.06B
19.14%8.49B
14.96%8.95B
19.36%9.48B
-14.78%6.56B
-11.38%7.13B
Minority interests
-60.66%107.43M
-56.70%126.63M
-53.02%152.77M
-42.16%169.39M
-21.66%273.09M
-27.03%292.43M
-37.06%325.14M
-21.13%292.83M
9,384,251.66%348.6M
10,791,346.13%400.74M
Total shareholder equity
-24.68%6.28B
-24.82%6.6B
-24.32%7.02B
-25.12%7.32B
20.76%8.34B
16.68%8.79B
11.72%9.27B
17.56%9.78B
-10.25%6.9B
-6.40%7.53B
Total liabilityies and equity
-6.30%10.86B
-6.71%10.99B
-0.88%12.02B
-9.68%11.34B
20.94%11.59B
19.15%11.78B
10.75%12.13B
13.81%12.56B
-0.11%9.58B
-1.41%9.89B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Rong Cheng Certified Public Accountants (Special General Partnership)
--
--
--
Rong Cheng Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds -40.64%2.47B-44.45%2.71B-9.10%4.56B-37.19%3.79B36.03%4.17B40.62%4.88B17.75%5.02B71.98%6.03B-2.63%3.06B-18.70%3.47B
Transactional financial assets --570M--600M------------------400M------------
Notes receivable and accounts receivable 27.63%466.69M-7.78%449.9M63.98%492.08M102.88%483.23M26.27%365.65M126.23%487.86M-14.86%300.08M-81.69%238.19M-61.23%289.59M-51.06%215.65M
-Accounts receivable 27.63%466.69M-7.78%449.9M63.98%492.08M102.88%483.23M26.27%365.65M126.23%487.86M-14.86%300.08M-81.58%238.19M-58.45%289.59M-43.75%215.65M
Other receivables (including interest and dividends) 118.62%201.57M328.22%201.79M772.70%230.54M1,328.69%374.01M371.18%92.2M57.86%47.12M-49.28%26.42M-6.68%26.18M-33.71%19.57M256.64%29.85M
-Other receivable ----328.22%201.79M----1,328.69%374.01M----57.86%47.12M-----6.68%26.18M----256.64%29.85M
Advance payment -0.51%283.15M6.93%267.24M-36.46%230.65M3.38%238.9M1.68%284.6M-24.01%249.92M-11.71%362.99M-40.71%231.08M-40.36%279.88M-18.84%328.87M
Inventories -24.13%567.44M-15.08%554.11M-7.70%535.55M-10.18%538.05M39.21%747.92M20.98%652.53M13.95%580.24M23.61%599.02M33.84%537.28M30.27%539.35M
Non-current assets due within one year 1,244.10%4.75M322.69%9.34M95.16%7.28M162.92%8.18M-85.18%353.16K12.96%2.21M60.73%3.73M103.07%3.11M2.82%2.38M-28.49%1.96M
Other current assets -85.93%17.33M-73.83%26.79M35.77%138.42M59.38%140.51M80.50%123.2M95.36%102.38M-29.16%101.95M-33.96%88.16M11.93%68.25M-10.43%52.4M
Total current assets -20.71%4.59B-24.95%4.82B-8.80%6.19B-22.80%5.57B35.69%5.78B38.46%6.42B18.50%6.79B23.47%7.22B-12.27%4.26B-17.15%4.64B
Non Current assets
Other equity investment -34.89%43.57M-26.99%56.13M-28.04%84.29M-38.76%84.18M-60.64%66.92M-36.50%76.89M-42.65%117.13M-45.79%137.46M-34.53%170.03M-45.61%121.09M
Other non-current financial assets -4.20%825.3M3.51%799.2M8.70%830.2M4.35%806.35M12.57%861.49M1.72%772.12M-2.33%763.76M-0.10%772.74M-0.86%765.3M6.49%759.1M
Fixed assets ----22.68%2.36B----28.36%2.43B----5.53%1.93B----0.66%1.89B-----4.17%1.83B
Constru in process ----26.28%1.53B----26.99%1.33B----28.06%1.21B----30.14%1.04B----81.67%943.33M
Intangible assets 41.70%526.5M71.28%533.02M73.29%540.3M73.04%546.96M16.63%371.57M-3.84%311.2M-3.52%311.8M19.29%316.09M94.17%318.6M94.39%323.64M
Long deferred expense -51.02%8.02M-46.48%10.82M-54.44%9.92M-45.79%12.6M-31.09%16.36M-19.96%20.21M-18.27%21.78M-16.37%23.24M-12.56%23.75M-6.10%25.25M
Deferred tax assets -41.72%103.2M-40.80%102.23M-55.56%100.55M-54.74%103.4M38.75%177.09M37.19%172.69M155.52%226.26M157.96%228.43M51.29%127.64M125.30%125.87M
Usufruct assets -11.50%50.61M-53.56%30.22M-40.87%43.36M-37.32%51.37M-65.12%57.18M-63.00%65.06M-40.78%73.32M-30.11%81.95M48.39%163.93M67.47%175.84M
Other non current assets 39.74%477.3M32.39%453.9M-48.04%186.65M-52.40%167.14M-2.61%341.56M-13.79%342.85M-19.13%359.19M-32.77%351.17M-34.71%350.7M-21.16%397.67M
Total non current assets 8.06%6.27B15.16%6.17B9.20%5.83B8.05%5.77B9.12%5.8B2.08%5.36B2.25%5.34B2.93%5.34B12.37%5.32B18.49%5.25B
Total assets -6.30%10.86B-6.71%10.99B-0.88%12.02B-9.68%11.34B20.94%11.59B19.15%11.78B10.75%12.13B13.81%12.56B-0.11%9.58B-1.41%9.89B
Liabilities
Current liabilities
Short term loan 86.04%631.66M93.37%667.17M249.13%1.23B28.77%452.44M-24.26%339.52M77.28%345.03M--353.12M--351.36M82,652.92%448.24M824.82%194.63M
Notes payable and accounts payable -11.15%984.19M-11.50%1.03B5.96%1.12B31.05%1.39B23.02%1.11B26.06%1.16B-35.35%1.06B-33.29%1.06B3.60%900.48M26.25%923.19M
-Notes payable ----------4.67M--4.67M------------------------
-Accounts payable -11.15%984.19M-11.50%1.03B5.52%1.12B30.61%1.38B23.02%1.11B26.06%1.16B-35.33%1.06B-33.27%1.06B3.63%900.48M26.25%923.19M
Contract liabilities 98.57%162.98M289.38%154.28M343.12%146.45M3,455.43%146.3M747.88%82.08M129.24%39.62M12.08%33.05M-91.02%4.11M-87.02%9.68M-70.76%17.28M
Salaries payable 50.46%232.6M38.33%191.85M61.54%258.23M22.04%234.2M10.93%154.59M22.56%138.69M12.85%159.85M-10.23%191.9M11.66%139.36M-18.93%113.16M
Taxs payable 70.48%35.57M48.08%36.31M22.13%29.65M44.51%50.74M-15.03%20.87M19.34%24.52M-52.37%24.28M-53.85%35.11M-26.16%24.56M-14.36%20.55M
Other payable (including interest and dividends) -8.83%36.18M34.75%43.64M49.98%50.41M-11.61%37.33M38.14%39.69M-24.59%32.39M-0.00%33.61M37.55%42.23M-26.96%28.73M-14.10%42.95M
-Other payable ----34.75%43.64M-----11.61%37.33M-----24.59%32.39M----37.55%42.23M-----14.10%42.95M
Non current liabilities due within one year 103.24%213.79M63.01%154.43M27.36%122.11M46.20%122.89M28.46%105.19M27.15%94.74M55.87%95.88M86.50%84.05M108.16%81.89M-84.18%74.51M
Other current liabilities -97.97%617.7315,811.73%8.56M12,383.07%8.54M11,483.62%8.69M-75.64%30.42K-89.05%53.82K-92.13%68.42K-98.46%74.99K-98.69%124.86K-94.93%491.66K
Total current liabilities 24.18%2.3B24.33%2.29B68.94%2.97B38.05%2.44B13.27%1.85B32.60%1.84B-10.05%1.76B-11.75%1.77B37.17%1.63B-7.89%1.39B
Current liabilities
Estimate liabilities --17.62M--17.62M--20.47M--27.1M------------------------
Long term deferred income 2.21%175.54M4.50%177.2M19.97%180.92M50.31%183.46M40.50%171.74M38.61%169.58M26.20%150.8M-0.33%122.06M8.49%122.24M20.33%122.34M
Lease liabilities -1.72%24.8M-68.47%9.52M-60.47%15.32M-62.54%17.45M-81.56%25.23M-78.92%30.2M-58.72%38.74M-49.98%46.58M50.99%136.79M70.35%143.22M
Other non current liabilities -1.02%157.02M743.09%155.6M2,696.13%161.45M2,032.92%160.05M1,770.45%158.64M115.96%18.46M-42.63%5.77M-34.74%7.5M-35.66%8.48M-42.94%8.55M
Total non current liabilities 62.94%2.28B81.65%2.1B85.29%2.04B55.93%1.58B34.12%1.4B19.10%1.16B57.44%1.1B41.65%1.02B47.46%1.04B103.09%969.9M
Total liabilities 40.88%4.58B46.44%4.38B75.23%5.01B44.58%4.02B21.40%3.25B27.04%2.99B7.73%2.86B2.34%2.78B41.00%2.68B18.84%2.36B
Shareholders equity
Paid-in capital 0.00%985.69M0.00%985.69M0.00%985.69M0.29%985.69M8.01%985.69M8.01%985.69M8.23%985.69M7.92%982.87M0.20%912.6M0.20%912.6M
Capital reserve funds -0.01%15.39B0.04%15.39B0.10%15.39B0.32%15.39B32.19%15.4B32.43%15.39B31.34%15.38B34.34%15.35B7.57%11.65B7.43%11.62B
Retained profit -22.04%-9.99B-24.84%-9.71B-27.64%-9.34B-33.70%-9.06B-36.77%-8.18B-46.65%-7.77B-52.98%-7.32B-54.42%-6.78B-47.38%-5.98B-44.90%-5.3B
Less:Treasury stock 105.54%30.89M--30.89M--29.89M--26.89M--15.03M--------------------
Other composite income -59.48%-190.01M-56.13%-166.41M-47.32%-141.21M-107.67%-142.07M-467.82%-119.14M-3.72%-106.59M-90.29%-95.86M-32,803.91%-68.41M-246.80%-20.98M-325.78%-102.76M
Shareholders equity without minority interests -23.46%6.17B-23.73%6.48B-23.28%6.87B-24.59%7.15B23.02%8.06B19.14%8.49B14.96%8.95B19.36%9.48B-14.78%6.56B-11.38%7.13B
Minority interests -60.66%107.43M-56.70%126.63M-53.02%152.77M-42.16%169.39M-21.66%273.09M-27.03%292.43M-37.06%325.14M-21.13%292.83M9,384,251.66%348.6M10,791,346.13%400.74M
Total shareholder equity -24.68%6.28B-24.82%6.6B-24.32%7.02B-25.12%7.32B20.76%8.34B16.68%8.79B11.72%9.27B17.56%9.78B-10.25%6.9B-6.40%7.53B
Total liabilityies and equity -6.30%10.86B-6.71%10.99B-0.88%12.02B-9.68%11.34B20.94%11.59B19.15%11.78B10.75%12.13B13.81%12.56B-0.11%9.58B-1.41%9.89B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Rong Cheng Certified Public Accountants (Special General Partnership)------Rong Cheng Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme AH Stocks
AH Stocks
Intraday-1.75%
ShangHai Stock Connect
ShangHai Stock Connect
Intraday-1.84%
Monoclonal Antibody Concept
Monoclonal Antibody Concept
Intraday-1.90%